<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The potent and selective AMPA receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> NBQX was tested for cytoprotective properties in an adult rat model of transient focal neocortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nineteen spontaneously hypertensive rats sustained 2 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, followed by 22 h of recirculation </plain></SENT>
<SENT sid="2" pm="."><plain>Ninety minutes following the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, at the time of, and 30 min following reperfusion, they received i.p. injections of either saline (n = 10) or 30 mg kg-1 of NBQX (n = 9) </plain></SENT>
<SENT sid="3" pm="."><plain>Saline-treated rats had a mean volume of neocortical infarction ( +/- s.d.) of 181 +/- 31 mm3, while NBQX-treated rats sustained significantly less damage, 125 +/- 19 mm3 (p less than 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Regional cerebral blood flows during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion were not affected by the drug </plain></SENT>
<SENT sid="5" pm="."><plain>We suggest that the AMPA receptor may play an important role in <z:e sem="disease" ids="C1262005" disease_type="Disease or Syndrome" abbrv="">ischemic cerebral infarction</z:e> </plain></SENT>
</text></document>